A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment
Advanced Science · 2024-05 · 11 (17)
DOI: 10.1002/advs.202305877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.03.2024. Verfasst von Na Yin und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. Hauptthemen laut MEDLINE: Microglia, Disease Models, Animal, Extracellular Traps, Ischemic Stroke. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Science Foundation of China, Outstanding Youth Foundation of Henan Province Henan.
Themen: Schlaganfall
Abstract (Originalsprache)
Precise and efficient regulation of microglia is vital for ischemic stroke therapy and prognosis. The infiltration of neutrophils into the brain provides opportunities for regulatory drugs across the blood–brain barrier, while hindered by neutrophil extracellular traps (NETs) and targeted delivery of intracerebral drugs to microglia. This study reports an efficient neutrophil hijacking nanoplatform (referred to as APTS) for targeted A151 (a telomerase repeat sequence) delivery to microglia without the generation of NETs. In the middle cerebral artery occlusion (MCAO) mouse model, the delivery efficiency to ischemic stroke tissues increases by fourfold. APTS dramatically reduces the formation of NETs by 2.2‐fold via reprogramming NETosis to apoptosis in neutrophils via a reactive oxygen species scavenging‐mediated citrullinated histone 3 inhibition pathway. Noteworthy, A151 within neutrophils is repackaged into apoptotic bodies following the death pattern reprogramming, which, when engulfed by microglia, polarizes microglia to an anti‐inflammatory M2 phenotype. After four times treatment, the cerebral infarction area in the APTS group decreases by 5.1‐fold. Thus, APTS provides a feasible, efficient, and practical drug delivery approach for reshaping the immune microenvironment and treating brain disorders in the central nervous system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
- Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, China.
- Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.
ORCID-Profile: Jinjin Shi
Förderung
- National Natural Science Foundation of China
- Postdoctoral Science Foundation of China
- Outstanding Youth Foundation of Henan Province Henan
Zitieren
APA
Yin, N., Wang, W., Pei, F., Zhao, Y., Liu, C., Guo, M., Zhang, K., Zhang, Z., Shi, J., Zhang, Y., Wang, Z. H., & Liu, J. (2024). A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment. Advanced Science, 11(17). https://doi.org/10.1002/advs.202305877
Vancouver
Yin N, Wang W, Pei F, Zhao Y, Liu C, Guo M, et al. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment. Advanced Science. 2024;11(17). doi:10.1002/advs.202305877
BibTeX
@article{Yin2024,
author = {Yin, Na and Wang, Wenya and Pei, Fei and Zhao, Yuzhen and Liu, Changhua and Guo, Mingming and Zhang, Kaixiang and Zhang, Zhenzhong and Shi, Jinjin and Zhang, Yun and Wang, Zhi-Hao and Liu, Junjie},
title = {A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {17},
doi = {10.1002/advs.202305877}
}
EUVIMED